Investigation into the potential of methylene blue and its derivatives to be used in the photodynamic therapy of non-pigmented and pigmented cells
Photodynamic therapy (PDT) is a novel treatment for malignant disease. The first step is intravenous injection of a light-absorbing, cytotoxic drug (the photosensitizer) that is then allowed time to accumulate in malignant tissue. The second step involves local activation of the photosensitizer with...
Main Author: | Rice, Lesley |
---|---|
Published: |
University of Central Lancashire
2001
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.369702 |
Similar Items
-
Novel Drug Delivery Approaches to Photodynamic Therapy
by: Morrow, D. I. J.
Published: (2008) -
Mechanisms underlying the erythemal response to topical 5-aminolaevulinic acid photodynamic therapy
by: Brooke, Rebecca C. C.
Published: (2010) -
Synthesis and testing of novel porphyrins for use in photodynamic therapy
by: Sorensen, Alexandra M. P. Santana
Published: (1997) -
Novel photosensitisers for use in photodynamic therapy
by: Boyle, Ross W.
Published: (1989) -
The regulation of cell survival signalling and apoptosis by the plant-derived cannabinoid -9-tetrahydrocannabinol and its potential as a novel agent for colorectal cancer therapy
by: Greenhough, Alexander
Published: (2009)